Introduction
Methods
Patients
Statistics
Results
Country | Netherlands | Belgium | Switzerland | Germany (MCR) | Ireland | Portugal (ROR-Sul) | USA |
P value | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cases | % | Cases | % | Cases | % | Cases | % | Cases | % | Cases | % | Cases | % | ||
Age | |||||||||||||||
65–69 | 10,162 | 28.6 | 2,337 | 33.1 | 465 | 32.1 | 4,539 | 39.3 | 1,295 | 30.0 | 40 | 32.3 | 36,629 | 25.3 | 0.9 |
70–74 | 9,636 | 27.1 | 1,818 | 25.8 | 365 | 25.2 | 3,077 | 26.7 | 1,142 | 26.5 | 40 | 32.3 | 35,109 | 24.2 | |
75–79 | 6,982 | 19.6 | 1,503 | 21.3 | 273 | 18.8 | 2,322 | 20.1 | 901 | 20.9 | 23 | 18.5 | 33,279 | 23.0 | |
80–84 | 5,260 | 14.8 | 907 | 12.9 | 171 | 12.0 | 1,152 | 10.0 | 631 | 14.6 | 13 | 10.5 | 23,592 | 16.3 | |
85–89 | 2,687 | 7.6 | 340 | 4.8 | 100 | 7.2 | 376 | 3.3 | 271 | 6.3 | 7 | 5.6 | 11,678 | 8.1 | |
90+ | 853 | 2.4 | 153 | 2.2 | 50 | 3.5 | 73 | 0.6 | 72 | 1.7 | 1 | 0.8 | 4,561 | 3.1 | |
Stage | |||||||||||||||
I | 15,894 | 44.7 | 3,331 | 47.2 | 657 | 46.0 | 5,471 | 47.4 | 1,476 | 34.2 | 55 | 44.4 | 90,402 | 62.4 | 0.06a
|
IIA | 13,288 | 37.3 | 3,028 | 42.9 | 530 | 37.2 | 4,120 | 35.7 | 1,867 | 43.3 | 47 | 37.9 | 39,109 | 27.0 | |
IIBb
| 6,398 | 18.0 | 699 | 9.9 | 237 | 16.6 | 1,948 | 16.9 | 969 | 22.5 | 22 | 17.7 | 15,337 | 10.6 | |
Grade | |||||||||||||||
1 | 5,316 | 14.9 | 1,193 | 16.9 | 314 | 22.0 | 1,503 | 13.0 | 476 | 11.0 | 17 | 13.7 | 36,182 | 25.0 | <0.001 |
2 | 12,036 | 33.8 | 2,983 | 42.3 | 794 | 55.8 | 6,888 | 59.7 | 1,890 | 43.8 | 81 | 65.3 | 61,178 | 42.2 | |
3/4 | 7,383 | 20.8 | 2,259 | 32.0 | 253 | 17.7 | 2,842 | 24.6 | 1,188 | 27.6 | 11 | 8.9 | 35,409 | 24.5 | |
Missing | 10,845 | 30.5 | 623 | 8.8 | 63 | 4.4 | 306 | 2.7 | 758 | 17.6 | 15 | 12.1 | 12,079 | 8.3 | |
Total | 35,580 | 100 | 7,058 | 100 | 1424 | 100 | 11,539 | 100 | 4,312 | 100 | 124 | 100 | 144,848 | 100 |